{"id":5461,"date":"2026-05-04T08:54:47","date_gmt":"2026-05-04T08:54:47","guid":{"rendered":"https:\/\/stock999.top\/?p=5461"},"modified":"2026-05-04T08:54:47","modified_gmt":"2026-05-04T08:54:47","slug":"gut-health-drugs-firm-enterobiotix-raises-19m-daily-business","status":"publish","type":"post","link":"https:\/\/stock999.top\/?p=5461","title":{"rendered":"Gut health drugs firm EnteroBiotix raises \u00a319m \u2013 Daily Business"},"content":{"rendered":"<p>            <\/p>\n<p>James McIlroy: building in Scotland<\/p>\n<p class=\"has-medium-font-size\">Drugs developer EnteroBiotix has raised \u00a319 million in one of the largest investments into a Scottish biotech company in recent years.<\/p>\n<p class=\"has-medium-font-size\">It will support one of the world\u2019s most extensive clinical trials of treatments for irritable bowel syndrome (IBS).\u00a0<\/p>\n<p class=\"has-medium-font-size\">IBS affects up to 1 in 10 of the global population, with up to twice as many women diagnosed compared to men.<\/p>\n<p class=\"has-medium-font-size\">The trial involving around 300 patients is now under way, with the drug manufactured by EnteroBiotix in Scotland. Results from the trial are due in the second half of 2027.\u00a0\u00a0<\/p>\n<p class=\"has-medium-font-size\">The funding round was led by life science investor Thairm Bio and the Scottish National Investment Bank, with participation from existing investors.<\/p>\n<p class=\"has-medium-font-size\">EnteroBiotix has raised in excess of \u00a365m since the company was founded by CEO Dr James McIlroy in 2017. He launched the company while training to be a doctor.<\/p>\n<p class=\"has-medium-font-size\">\u201cWe aim to address underlying disease biology and deliver clinically meaningful improvements in patient outcomes,\u201d he said.<\/p>\n<p class=\"has-medium-font-size\">\u201cOur mission is to redefine the standard of care in gastrointestinal disease, improving the lives of patients with IBS while building a leading global biopharmaceutical company from our base in Scotland.\u201d<\/p>\n<p class=\"has-medium-font-size\">EnteroBiotix\u2019s clinical pipeline spans IBS, liver cirrhosis, and blood cancer. The company, which is chaired by former Merck Serono CEO Elmar Schnee, has a number of strategic partnerships and research collaborations in place, including with Imperial College London.<\/p>\n<p>           \t            #Gut #health #drugs #firm #EnteroBiotix #raises #19m #Daily #Business<\/p>\n","protected":false},"excerpt":{"rendered":"<p>James McIlroy: building in Scotland Drugs developer EnteroBiotix has raised \u00a319 million in one of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[10882,272,306,758,10880,1159,6119,273,10881,1161],"_links":{"self":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/5461"}],"collection":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5461"}],"version-history":[{"count":0,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/5461\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}